A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Severe Steroid Dependent Asthma
Phase of Trial: Phase III
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Dupilumab (Primary) ; Prednisolone; Prednisolone; Prednisone; Prednisone
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms LIBERTY ASTHMA VENTURE; VENTURE
- Sponsors Sanofi
- 20 Nov 2017 Status changed from active, no longer recruiting to completed.
- 31 Oct 2017 Results published in a Sanofi Media Release.
- 31 Oct 2017 According to a Regeneron Pharmaceuticals media release, detailed results from this study will be submitted for presentation at a future medical congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History